Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1999 Jan;90(1):1–5. doi: 10.1111/j.1349-7006.1999.tb00658.x

Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation

Akira Miyauchi 1,✉, Hitoyasu Futami 2, Noritaka Hai 4,5, Tamotsu Yokozawa 1, Kanji Kuma 1, Norihiko Aoki 5, Shinji Kosugi 4, Kokichi Sugano 3, Ken Yamaguchi 2
PMCID: PMC5925979  PMID: 10076558

Abstract

Multiple endocrine neoplasia (MEN) type 2B is a clinically distinct entity among the autosomal dominant MEN 2 syndromes. Most patients with MEN 2B carry a germline mutation (M918T) of the RET proto‐oncogene, while a few carry A883F. We examined a patient with MEN 2B, but without M918T or A883F, and her relatives. Here, we report the presence in this patient of 2 germline mutations, V804M and Y806C in the same allele. While the novel Y806C was inherited from her father, its carriers (her father and brother) was not affected by MEN 2. In contrast, V804M was a de novo mutation, that has been reported in patients with familial medullary thyroid carcinoma. Combinations of mutations of the RET proto‐oncogene may cause oncogenic activities different from those of single mutations.

Keywords: Multiple endocrine neoplasia 2B, RET proto‐oncogene, Germline mutation, V804M, Y806C

Full Text

The Full Text of this article is available as a PDF (256.8 KB).

REFERENCES

  • 1. ) Mulligan , L. M. , Marsh , D. J. , Robinson , B. G. , Schuffenecker , I. , Zedenius , J. , Lips , C. J. , Gag el , R. F. , Takai , S. I. , Noll , W. W. , Fink , M. , Raue , F. , Lacroix , A. , Thibodeau , S. N. , Frilling , A. , Ponder , B. A. J. and Eng , C.for the International RET Mutation Consortium. Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium . J. Intern. Med. , 238 , 343 – 346 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Schimke , R. N. , Hartmann , W. H. , Prout , T. W. and Rimoin , D. L.Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas . N. Engl. J. Med. , 279 , 1 – 7 ( 1968. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Gorlin , R. J. , Sedano , H. O. , Vickers , R. A. and Cervenka , J.Multiple mucosal neuromas, phaeochromocytoma and medullary carcinoma of the thyroid – a syndrome . Cancer , 22 , 293 – 299 ( 1968. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Mulligan , L. M. and Ponder , B. A. J.Genetic basis of endocrine disease. Multiple endocrine neoplasia type 2 . J. Clin. Endocrinol. Metab. , 80 , 1989 – 1995 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Eng , C. , Smith , D. P. , Mulligan , L. M. , Healey , C. S. , Zvelebil , M. J. , Stonehouse , T. J. , Ponder , M. A. , Jackson , C. E. , Waterfield , M. D. and Ponder , B. A. J.A novel point mutation in the tyrosine kinase domain of the RET proto‐oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC . Oncogene , 10 , 509 – 513 ( 1995. ). [PubMed] [Google Scholar]
  • 6. ) Bolino , A. , Schuffenecker , I. , Luo , Y. , Seri , M. , Silengo , M. , Tocco , T. , Chabrier , G. , Houdent , C. , Murat , A. , Schlumberger , M. , Tourinaire , J. , Lenoir , G. M. and Romeo , G.RET mutations in exons 13 and 14 of FMTC patients . Oncogene , 10 , 2415 – 2419 ( 1995. ). [PubMed] [Google Scholar]
  • 7. ) Fink , M. , Weinhasel , A. , Niederle , B. and Haas , O. A.Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto‐oncogene . Int. J. Cancer , 69 , 312 – 316 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Hofstra , R. M. W. , Fattoruso , O. , Quadro , L. , Wu , Y. , Libroia , A. , Verga , U. , Colantuoni , V. and Buys , C. H. C. M.A novel point mutation in the intracellular domain of the RET protooncogene in a family with medullary thyroid carcinoma . J. Clin. Endocrinol. Metab. , 82 , 4176 – 4178 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Eng , C. , Clayton , D. , Schuffernecker , I. , Lenoir , G. , Cote , G. , Gagel , R. F. , van Amstel , H. K. , Lips , C. J. , Nishisho , I. , Takai , S. , Marsh , D. J. , Robinson , B. G. , Frank‐Raue , K. , Raue , F. , Xue , F. , Noll , W. W. , Romei , C. , Pacini , F. , Fink , M. , Niederle , B. , Zedenius , J. , Nordenskjold , M. , Komminoth , P. , Hendy , G. N. and Mulligan , L. M.The relationship between specific RET proto‐oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis . JAMA , 276 , 1575 – 1579 ( 1996. ). [PubMed] [Google Scholar]
  • 10. ) Gimm , O. , Marsh , D. J. , Andrew , S. D. , Frilling , A. , Dahia , P. L. M. , Mulligan , L. M. , Zajac , J. D. , Robinson , B. G. and Eng , C.Germline dinucleotide mutation in codon 883 of the RET proto‐oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation . J. Clin. Endocrinol. Metab. , 82 , 3902 – 3904 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Smith , D. P. , Houghton , C. and Ponder , B. A. J.Germline mutation of RET codon 883 in two cases of de novo MEN 2B . Oncogene , 15 , 1213 – 1217 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Egawa , S. , Futami , H. , Takasaki , K. , Lihara , M. , Okamoto , T. , Kanbe , M. , Ohi , T. , Saio , Y. , Miyauchi , A. , Takiyama , Y. , Koga , M. , Miyanaga , K. , Inoue , K. , Mitsuyama , S. , Nomura , Y. , Takei , H. , Mugiya , S. , Ishida , O. , Zeze , F. , Shakutsui , S. , Inoue , H. , Oya , H. , Yoshimura , A. , Ishizuka , S. , Tsujino , T. , Obara , T. and Yamaguchi , K.Genotype‐phenotype correlation of the patients with multiple endocrine neoplasia type 2 in Japan . Jpn. J. Clin. Oncol. , 28 , 590 – 596 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Ceccherini , I. , Hofstra , R. M. W. , Luo , Y. , Stulp , R. P. , Barone , V. , Stelwagen , T. , Bocciardi , R. , Nijveen , H. , Bolino , A. , Seri , M. , Ronchetto , P. , Pasini , B. , Bozzano , M. , Buys , C. H. C. M. and Romeo , G.DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto‐oncogene . Oncogene , 9 , 3025 – 3029 ( 1994. ). [PubMed] [Google Scholar]
  • 14. ) Uchino , S. , Noguchi , S. , Adachi , M. , Sato , M. , Yamashita , H. , Watanabe , S. , Murakami , T. , Toda , M. , Murakami , N. and Yamashita , H.Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas . Jpn. J. Cancer Res. , 89 , 411 – 418 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Scurini , C. , Quadro , L. , Fattoruso , O. , Verga , U. , Livroia , A. , Lupoli , G. , Cascone , E. , Marzano , L. , Paracchi , S. , Bus‐nardo , B. , Girelli , M. E. , Bellastella , A. and Colantuoni , V.Germline and somatic mutations of the RET proto‐oncogene in apparently sporadic medullary thyroid carcinomas . Mol. Cell Endocrinol. , 137 , 51 – 57 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Santoro , M. , Carlomagno , F. , Romano , A. , Bottaro , D. P. , Dathan , N. A. , Grieco , M. , Fusco , A. , Vecchio , G. , Matoskova , B. , Kraus , M. H. and Fiole , P. P. D.Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B . Science , 267 , 381 – 383 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Pasini , A. , Geneste , O. , Legrand , P. , Schlumberger , M. , Rossel , M. , Fournier , L. , Rudkin , B. B. , Schuffenecker , I. , Lenoir , G. M. and Billaud , M.Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain . Oncogene , 15 , 393 – 402 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Carlson , K. M. , Dou , S. , Chi , D. , Scavarda , N. , Toshima , K. , Jackson , C. E. , Wells , S. A. , Jr. , Goodfellow , P. J. and Donis‐Keller , H.Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B . Proc. Natl. Acad. Sci. USA , 91 , 1579 – 1583 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Marsh , D. J. , Andrew , S. D. , Eng , C. , Learoyd , D. L. , Capes , A. G. , Pojer , R. , Richardson , A. L. , Houghton , C. , Mulligan , L. M. , Ponder , B. A. J. and Robinson , B. G.Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma . Cancer Res. , 56 , 1241 – 1243 ( 1996. ). [PubMed] [Google Scholar]
  • 20. ) Miyauchi , A. , Egawa , S. , Futami , H. , Kuma , K. , Obara , T. and Yamaguchi , K.A novel somatic mutation in the RET proto‐oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation . Jpn. J. Cancer Res. , 88 , 527 – 531 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES